Cargando…
Signaling through hepatocyte vasopressin receptor 1 protects mouse liver from ischemia-reperfusion injury
Terlipressin has been used extensively in the management of certain complications associated with end-stage liver diseases (ESLDs). In our pilot study, terlipressin treatment showed beneficial effects on liver function in patients with decompensated cirrhosis, however whether it plays a role in live...
Autores principales: | Liu, Xiqiang, Luo, Gaojian, Jiang, Jingbo, Ma, Tonghui, Lin, Xiaozhu, Jiang, Liping, Cheng, Jilin, Tao, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342477/ https://www.ncbi.nlm.nih.gov/pubmed/27713143 http://dx.doi.org/10.18632/oncotarget.12472 |
Ejemplares similares
-
Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury
por: Liu, Xiqiang, et al.
Publicado: (2015) -
Protective Effects of Syringic Acid on Ischemia-Reperfusion Injury in Testicular Torsion: An Experimental Study in a Rat Model
por: Sarikaya, Kubilay, et al.
Publicado: (2023) -
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
por: Brunner, Stefanie N., et al.
Publicado: (2017) -
Berberine nanoparticles protects tubular epithelial cells from renal ischemia-reperfusion injury
por: Xie, Da, et al.
Publicado: (2017) -
Hepatocyte apoptosis is enhanced after ischemia/reperfusion in the steatotic liver
por: Suzuki, Takeshi, et al.
Publicado: (2011)